ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 46 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $354 | -25.5% | 325 | 0.0% | 0.00% | – |
| Q4 2022 | $475 | -52.5% | 325 | +91.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 170 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 170 | +70.0% | 0.00% | – |
| Q1 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 100 | -39.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 164 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 164 | +64.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -66.7% | 100 | -75.0% | 0.00% | -100.0% |
| Q3 2016 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $2,341,000 | 3.33% |
| Matrix Capital Management Company, LP | 38,974,185 | $66,256,000 | 1.50% |
| NEA Management Company, LLC | 17,082,612 | $29,040,000 | 1.49% |
| Endurant Capital Management LP | 1,824,065 | $3,101,000 | 1.09% |
| Long Focus Capital Management, LLC | 4,679,491 | $7,955,000 | 0.83% |
| Key Client Fiduciary Advisors, LLC | 416,166 | $707,000 | 0.69% |
| PFM Health Sciences, LP | 9,109,780 | $15,487,000 | 0.59% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $153,000 | 0.21% |
| DAFNA Capital Management LLC | 351,064 | $597,000 | 0.16% |
| Rock Springs Capital Management LP | 2,357,544 | $4,008,000 | 0.12% |